Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 24 Mar 2025
The world's woes got you down? Feeling burnout at work? Need a little something extra to fight illness or prep for surgery? The Swiss town of Neuchâtel is offering its residents a novel medical option: Expose yourself to ...
Read Full NewsAripiprazole is associated with a lower risk for hyponatremia compared with olanzapine in patients treated with second-generation antipsychotics, a new cohort study shows.
Researchers evaluate changes in post-transplantation outcomes among patients with relapsed or refractory Hodgkin lymphoma from 2010 to 2022.
In a recent KFF survey, 43% of US adults said they had skipped their medication in the past year because of cost.
1.
Psychedelic Therapy Tied to Reduced Depression, Anxiety.
2.
Frontline EGFR/VEGF Inhibition Slows Advanced EGFR-Positive Lung Cancer
3.
Taking vitamin D daily decreased cancer mortality, according to a study.
4.
Study reveals increase in late-stage breast cancer diagnoses in US
5.
Prostate cancer Q&A: Improving detection and reducing overtreatment
1.
Virtual Survivorship Platforms in Cancer Care: Transforming Post-Treatment Support and Outcomes
2.
Unlocking the Potential of Talquetamab: A Revolutionary Approach to Cancer Treatment
3.
Emerging Therapies and Technologies Reshaping Oncology: Innovations and Impact in 2025
4.
The Importance of Understanding Your D-Dimer Levels: A Comprehensive Guide
5.
Women's Cancer Survivorship: Emerging Long-Term Health Priorities
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
2.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII
3.
Expert Perspectives on Hematology
4.
Current Scenario of Cancer- Final Discussion on the Importance of Genomic Testing & Advancement in Diagnosis and Treatment
5.
Navigating the Complexities of Ph Negative ALL - Part VIII
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge